1. Home
  2. QUBT vs BHVN Comparison

QUBT vs BHVN Comparison

Compare QUBT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum Computing Inc.

QUBT

Quantum Computing Inc.

HOLD

Current Price

$8.57

Market Cap

1.7B

Sector

Technology

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$13.27

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUBT
BHVN
Founded
2001
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
2.1B
IPO Year
2019
2022

Fundamental Metrics

Financial Performance
Metric
QUBT
BHVN
Price
$8.57
$13.27
Analyst Decision
Buy
Buy
Analyst Count
6
14
Target Price
$17.50
★ $29.08
AVG Volume (30 Days)
★ 6.0M
2.9M
Earning Date
05-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 84.93
26.08
EPS
★ N/A
N/A
Revenue
★ $682,000.00
N/A
Revenue This Year
$3,210.56
N/A
Revenue Next Year
$51.26
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 82.84
N/A
52 Week Low
$6.18
$7.48
52 Week High
$25.84
$18.57

Technical Indicators

Market Signals
Indicator
QUBT
BHVN
Relative Strength Index (RSI) 52.30 45.06
Support Level $7.72 $8.75
Resistance Level $9.25 $14.52
Average True Range (ATR) 0.37 0.95
MACD 0.10 -0.05
Stochastic Oscillator 48.36 33.99

Price Performance

Historical Comparison
QUBT
BHVN

About QUBT Quantum Computing Inc.

Quantum Computing Inc is an integrated photonics and non-linear quantum optics company to develop and deliver machines for quantum computing, reservoir computing, and remote sensing, imaging, and cybersecurity applications based on patented and proprietary photonics technology. Its products are designed to operate at room temperature and low power at an affordable cost. The Company's portfolio of core technologies and products offers capabilities in the areas of high-performance computing, artificial intelligence, and cybersecurity, as well as remote sensing applications.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.

Share on Social Networks: